NOW, THEREFORE, in consideration of the mutual promises contained WHEREAS, Genentech and Connetics therefore agree to undertake the foregoing, all under the terms and conditions set forth in this Agreement andįor the consideration set forth herein and in the Stock Agreement. Obligations created pursuant hereto in lieu of the rights and obligations under the Prior Agreement and WHEREAS, Connetics and Genentech are parties to that certain Agreement on Interferon Gamma-1B datedĭecember 8, 1995 (the Prior Agreement) and desire to terminate the Prior Agreement effective as of the date hereof and to accept the rights and Under the terms and conditions set forth in that certain supply agreement between Genentech and Connetics of even date herewith (the Supply Agreement) WHEREAS, Genentech will manufacture and supply Connetics with Interferon Gamma-1B (as defined herein) WHEREAS, in consideration for the foregoing, Connetics will issue to Genentech shares of Connetics Common Stock on the terms and conditions setįorth in that certain stock purchase agreement between Genentech and Connetics of even date herewith (the Stock Agreement)
Use, sell, offer for sale and import Interferon Gamma (as defined herein) in the United States for the treatment of certain medical disorders
Actimmune interferon gamma copay assistance program license#
WHEREAS, Connetics wishes to obtain a non-exclusive license to manufacture and an exclusive license to (∼onnetics), and Genentech, Inc., a Delaware corporation with its principal office at 1 DNA Way, South San Francisco, California 94080 (Genentech).
With the Securities and Exchange Commission.Īgreement is entered into effective as of May 5, 1998, (∾ffective Date) by and between Connetics Corporation, a Delaware corporation with its principal office at 3400 West Bayshore Road, Palo Alto, California 94303
0 kommentar(er)
